EP 1343803 A2 20030917 - 2-SUBSTITUTED ESTROGENS AS ANTIANGIOGENIC AGENTS
Title (en)
2-SUBSTITUTED ESTROGENS AS ANTIANGIOGENIC AGENTS
Title (de)
2-SUBSTITUIERTE ESTROGENE MIT ANTIANGIOGENISCHER AKTIVITÄT
Title (fr)
ESTROGENES SUBSTITUES EN POSITION 2 COMME AGENTS ANTIANGIOGENIQUES
Publication
Application
Priority
- US 0126490 W 20010824
- US 25338500 P 20001127
- US 25530200 P 20001213
- US 27825001 P 20010323
- US 93389401 A 20010821
Abstract (en)
[origin: WO0242319A2] Compositions and methods for treating mammalian disease characterized by undesirable angiogenesis by administering derivatives of 2-methoxyestradiol of the general formula (I), wherein the variables are defined in the specification.
IPC 1-7
C07J 1/00; C07J 13/00; C07J 41/00; C07J 9/00; C07J 3/00; C07J 7/00; A61K 31/56; A61P 35/00
IPC 8 full level
A61K 31/565 (2006.01); A61K 31/566 (2006.01); A61K 31/567 (2006.01); A61K 31/57 (2006.01); A61K 31/575 (2006.01); A61P 1/04 (2006.01); A61P 9/00 (2006.01); A61P 9/10 (2006.01); A61P 27/02 (2006.01); A61P 29/00 (2006.01); A61P 31/04 (2006.01); A61P 35/00 (2006.01); A61P 43/00 (2006.01); C07J 1/00 (2006.01); C07J 3/00 (2006.01); C07J 7/00 (2006.01); C07J 9/00 (2006.01); C07J 13/00 (2006.01); C07J 41/00 (2006.01)
CPC (source: EP)
A61P 1/04 (2017.12); A61P 9/00 (2017.12); A61P 9/10 (2017.12); A61P 27/02 (2017.12); A61P 29/00 (2017.12); A61P 31/04 (2017.12); A61P 35/00 (2017.12); A61P 43/00 (2017.12); C07J 1/00 (2013.01)
Citation (search report)
See references of WO 0242319A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 0242319 A2 20020530; WO 0242319 A3 20030313; WO 0242319 A9 20050331; AU 2001288386 B2 20061102; AU 8838601 A 20020603; CA 2430100 A1 20020530; EP 1343803 A2 20030917; JP 2004537499 A 20041216
DOCDB simple family (application)
US 0126490 W 20010824; AU 2001288386 A 20010824; AU 8838601 A 20010824; CA 2430100 A 20010824; EP 01968112 A 20010824; JP 2002544452 A 20010824